Friday 29 March 2024
 
»
Tag
 
»
Freienbach

FDA approves ‘osteoporosis’ tablet

EffRx Pharmaceuticals has announced that US Food and Drug Administration (FDA) has approved Binosto (alendronate sodium) Effervescent Tablets, previously known as EX101. The tablets are used for the treatment of osteoporosis in postmenopau

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Ads